This ICR collects information from manufacturers of infusion pumps who intend to submit a safety assurance case (assurance case) with their premarket notification (510(k)) submission. Based on the information provided in the premarket notification (510(k)) submission, FDA determines whether a new device provides reasonable assurance of the safety and effectiveness of the device through substantial equivalence to a legally marketed device and whether the device can, therefore, be allowed to enter the U.S. market. However, FDA also believes an assurance case can be used to support claims that a device is safe for use.
An assurance case is a systematic method of documenting a claim through a series of structured arguments, supported by a body of evidence that provides a compelling, comprehensible and valid case that the claim is true.
Manufacturers submitting a 510(k) for modifications to a legally marketed infusion pump for which no assurance case exists, should develop and submit an assurance case for their infusion pump.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.